Clinical Trial Update: Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

View source ↗

Summary

Update on a clinical trial evaluating the Spectrosense EVA System for detecting breast cancer by analyzing volatile organic compounds in exhaled air.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Spectrosense EVA System

Snippet

Sponsor: Rauscher, Gregory E., M.D. PA | Conditions: Breast Cancer | Status: UNKNOWN